178 related articles for article (PubMed ID: 38388931)
41. Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial.
Li Z; Shan F; Ying X; Xue K; Ji J
BMC Cancer; 2018 Nov; 18(1):1118. PubMed ID: 30445943
[TBL] [Abstract][Full Text] [Related]
42. Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
Dos Santos M; Lequesne J; Leconte A; Corbinais S; Parzy A; Guilloit JM; Varatharajah S; Brachet PE; Dorbeau M; Vaur D; Weiswald LB; Poulain L; Le Gallic C; Castera-Tellier M; Galais MP; Clarisse B
BMC Cancer; 2022 May; 22(1):537. PubMed ID: 35549674
[TBL] [Abstract][Full Text] [Related]
43. Laparoscopic gastrectomy for gastric cancer: current evidences.
Lianos GD; Rausei S; Ruspi L; Galli F; Mangano A; Roukos DH; Dionigi G; Boni L
Int J Surg; 2014 Dec; 12(12):1369-73. PubMed ID: 25448659
[TBL] [Abstract][Full Text] [Related]
44. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract][Full Text] [Related]
45. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X; Liang H; Li Z; Xue Y; Wang Y; Zhou Z; Yu J; Bu Z; Chen L; Du Y; Wang X; Wu A; Li G; Su X; Xiao G; Cui M; Wu D; Chen L; Wu X; Zhou Y; Zhang L; Dang C; He Y; Zhang Z; Sun Y; Li Y; Chen H; Bai Y; Qi C; Yu P; Zhu G; Suo J; Jia B; Li L; Huang C; Li F; Ye Y; Xu H; Wang X; Yuan Y; E JY; Ying X; Yao C; Shen L; Ji J;
Lancet Oncol; 2021 Aug; 22(8):1081-1092. PubMed ID: 34252374
[TBL] [Abstract][Full Text] [Related]
46. Combined modality therapy of localized gastric and esophageal cancers.
Das P; Fukami N; Ajani JA
J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
[TBL] [Abstract][Full Text] [Related]
47. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Shah MA; Kennedy EB; Alarcon-Rozas AE; Alcindor T; Bartley AN; Malowany AB; Bhadkamkar NA; Deighton DC; Janjigian Y; Karippot A; Khan U; King DA; Klute K; Lacy J; Lee JJ; Mehta R; Mukherjee S; Nagarajan A; Park H; Saeed A; Semrad TJ; Shitara K; Smyth E; Uboha NV; Vincelli M; Wainberg Z; Rajdev L
J Clin Oncol; 2023 Mar; 41(7):1470-1491. PubMed ID: 36603169
[TBL] [Abstract][Full Text] [Related]
48. Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
Shi Y; Xu X; Zhao Y; Qian F; Tang B; Hao Y; Luo H; Chen J; Yu P
Surgery; 2019 Jun; 165(6):1211-1216. PubMed ID: 30772006
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic Advances in the Treatment of Gastroesophageal Cancers.
Li JJ; Rogers JE; Yamashita K; Waters RE; Blum Murphy M; Ajani JA
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238666
[TBL] [Abstract][Full Text] [Related]
50. Global Ring Study to Investigate the Comparability of Total Assay Performance of Commercial Claudin 18 Antibodies for Evaluation in Gastric Cancer.
Jasani B; Taniere P; Schildhaus HU; Blighe K; Parry S; Wilkinson D; Atkey N; Clare-Antony S; McCabe C; Quinn C; ; Dodson A
Lab Invest; 2024 Jan; 104(1):100284. PubMed ID: 37949357
[TBL] [Abstract][Full Text] [Related]
51. Laparoscopic versus open gastrectomy for gastric cancer.
Best LM; Mughal M; Gurusamy KS
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011389. PubMed ID: 27030300
[TBL] [Abstract][Full Text] [Related]
52. A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol).
Lee CM; Park JH; In Choi C; Lee HH; Min JS; Jee YS; Jeong O; Chae H; Choi SI; Huang H; Park S
BMC Cancer; 2019 Mar; 19(1):206. PubMed ID: 30845995
[TBL] [Abstract][Full Text] [Related]
53. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
54. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
55. The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.
Murphy AG; Kelly RJ
Hematol Oncol Clin North Am; 2017 Jun; 31(3):485-498. PubMed ID: 28501089
[TBL] [Abstract][Full Text] [Related]
56. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
Jung JO; Nienhüser H; Schleussner N; Schmidt T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023907
[TBL] [Abstract][Full Text] [Related]
57. [Clinical trials of laparoscopic gastric cancer surgery in South Korea: review and prospect].
Zhu C; Zhao G; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):154-159. PubMed ID: 29492913
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
de Moraes FCA; Pasqualotto E; Chavez MP; Ferreira ROM; De Castria TB; Burbano RMR
BMC Cancer; 2024 Feb; 24(1):240. PubMed ID: 38383390
[TBL] [Abstract][Full Text] [Related]
59. Advances in the treatment of gastric cancer: 2022-2023.
Ilson DH
Curr Opin Gastroenterol; 2023 Nov; 39(6):517-521. PubMed ID: 37678195
[TBL] [Abstract][Full Text] [Related]
60. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
